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Exercise is associated with release of inflammatory mediators in the circulation and there is evidence that the exercising muscles and
tendons are sources of interleukin-6. Due to the catabolic effects of some cytokines, increased release in circulation might contribute to
alterations in body composition in adults with cystic fibrosis. We hypothesised that exercise of moderate intensity would generate increased
blood concentrations of some inflammatory mediators.
We investigated the change in blood concentrations of interleukin-6, tumour necrosis factor alpha and their soluble receptors after a
structured exercise (box stepping) of intensity similar to that encountered during activities of daily living in 12 adults with cystic fibrosis and
mean (95% confidence interval) FEV1 55.6 (44.4, 66.8)% predicted, body mass index 23.0 (21.3, 24.6) kg/m
2 and 12 healthy subjects.
The increments post-exercise for all inflammatory mediators and lactate corrected for the work performed until voluntary exhaustion were
greater for patients, while the total work was less for patients (all p <0.01). Daytime variability of the inflammatory mediators was assessed in
eight patients and was less than the change due to exercise.
We report greater increments in circulating concentrations of some cytokines with moderate exercise in adults with cystic fibrosis
compared to healthy subjects.
D 2005 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Interleukin-6; Lactate; Box stepping; Work1. Introduction
Strenuous exercise in healthy individuals is associated
with an increase in the circulating concentrations of
interleukin (IL)-1h, IL-6, tumour necrosis factor-a (TNFa),
TNFa soluble receptor I (srI) and IL-1h receptor antagonist
[1]. The increase in IL-6 is the most consistently reported
response and is greater than changes reported for the other
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E-mail address: ionescuaa@cardiff.ac.uk (A.A. Ionescu).released from exercising muscle and tendons [3,4]. The
mechanism underlying this effect of exercise is unknown,
though muscle injury and repair, increased circulating
catecholamines and a homeostatic response to maintain
glucose supply to exercising muscle have been suggested
[5]. Whatever the mechanism, it is well established that the
increase in IL-6 is related to muscle contractions, to the type
of exercise and to the intensity and duration of exercise
[6,7].
There are few reports of the cytokine response to exercise
in disease states. Cooper and colleagues studied children
with CF expecting a blunting of the IL-6 response to
exercise secondary to raised circulating concentrations,
compared with healthy subjects [8,9]. Most adults with
CF and chronic pulmonary infection have increased levels5 (2006) 105 – 112ed by Elsevier B.V. All rights reserved.
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stable, which increase further during exacerbations of their
respiratory symptoms [10,11]. Cross-sectional studies
reported that increased levels of circulating inflammatory
mediators were related to markers of bone and cellular
protein catabolism and associated with loss of fat free mass
and reduced bone mineral density [10,12,13]. Additionally a
longitudinal study in CF found that persistently high
concentrations of immunoreactive IL-6 were related to a
low bone mineral content and urinary excretion of a bone
resorption marker [14]. Similar relationships between
increased circulating IL-6 and TNFa and a reduced skeletal
muscle mass and strength have been reported in healthy
elderly subjects and patients with COPD [15,16]. TNFa and
IL-6 were associated to increased protein catabolism and
cachexia [8,17,18]. Such studies offer circumstantial evi-
dence that some inflammatory mediators may play a part in
the systemic complications of chronic respiratory disease.
We hypothesised that adults with CF with a background
chronic acute phase like inflammatory response, parallel
catabolic intermediary metabolism and a likely lower
threshold for lactate production with exercise would have
greater increments in IL-6, TNFa and their soluble
receptors, compared with healthy age matched subjects,
for the total work performed during an episode of moderate
exercise. Additionally, we expected a relationship with
lactate production and the cardio-respiratory response to
exercise. To test this we assessed the inflammatory response
to a structured exercise test of an intensity similar to that
encountered during activities of daily living.2. Methods
2.1. Subjects
Twelve patients (6 male) with CF were studied after 14
days inpatient intra-venous antibiotic treatment for an
exacerbation of respiratory symptoms, when they were
likely to be at their best clinical status [10,11]. All patients
had a minimum of three isolations of Pseudomonas
aeruginosa from sputum in the preceding 6 months. Patients
had been diagnosed with CF according to the following
criteria: clinical findings, sweat Na+ and Cl >70 mmol/l and
all had a genotype DF508/DF508. Exclusion criteria were
long-term oral corticosteroid or non-steroidal anti-inflam-
matory medication, diabetes mellitus, liver cirrhosis, chronic
respiratory failure or cor pulmonale.
An exacerbation was defined as increased cough and
sputum production, loss of appetite with or without weight
loss and a reduction in FEV1 of more than 10% from the
usual value.
Twelve healthy subjects (5 male) not on a regular
exercise programme were also studied. The study had Local
Research Ethics Committee approval and participants gave
written informed consent.2.2. Protocol
Subjects were studied after a 15 min seated rest and at
least 2 h post-prandial. Blood was obtained pre-exercise,
post exercise, 30 and 120 min later from a cannulated hand
vein. Subjects box-stepped (height 20 cm) at 15 steps/min
set by a metronome and were encouraged to keep their trunk
erect and unsupported. A maximum time of 20 min was set
for the exercise, otherwise subjects could stop if exhausted,
and the reason for stopping the test was documented.
Oxygen uptake (VO2) and carbon dioxide output (VCO2)
were measured wearing a mask during the last 2 min of rest,
during exercise and through the recovery period until VO2
was within 10% of the pre-exercise values (K4b, Cosmed,
Italy). Measurements were made continuously during
exercise, but only those of the last minute were analysed.
Oxygen saturation was measured by finger pulse oximetery
(Critikon, Ohio). At the end of the exercise breathlessness
was assessed using the 10 point Borg scale.
Since the type of exercise (i.e. high work rate in short
bouts, or endurance-type) likely to trigger cytokine release
in patients with lung disease is largely unknown, we chose
to exercise subjects at a constant work rate (power) and the
total work performed was calculated.
Total work performed (kJ)=Power (W)* time (s), where
the power (W)=height of the step (m)*number of steps/
minute*subject’s weight (kg)*0.163 [19]. The work rate (in
metabolic equivalents-Mets, 1 Met=3.6 ml/kg/min) for the
last minute of exercise was calculated [20]. We used this
conversion as an estimate to allow us to compare the work
rate during exercise with work rates of habitual physical
activities recorded by questionnaire.
2.3. Repeatability of cytokine measures
Eight patients had repeated measurements of circulating
concentrations of inflammatory mediators. The inflamma-
tory mediators were measured on three occasions, 2 weeks
apart, in the morning and fasting conditions. All measure-
ments were recorded during clinical stability.
2.4. Other measurements
Habitual physical activity was assessed by questionnaire
and expressed in Mets [21]. Height, weight and body mass
index (BMI, kg/m2) were measured, fat free mass index
(FFMI) was derived from two site-skinfold thickness and
FEV1 was measured by spirometry.
2.5. Circulating biochemical parameters and inflammatory
mediators
Blood lactate was determined colorimetrically using
lactate oxidase (Pointe Scientific, USA). Glucose was
determined enzymatically using hexokinase (Diasys Diag-
nostic Systems GmbH (Germany). Insulin-like growth
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assay (IEMA), Immunodiagnostic Systems Ltd (IDS) (UK)
and cortisol by a solid phase Radioimmunoassay (RIA),
Diagnostic products corporation (DPC) (USA).
Interleukin-6 (IL-6) and tumour necrosis factor alpha
(TNFa) were measured by high sensitivity ELISA kit (R&D
systems Europe), assayed once in duplicate. TNFa soluble
receptors (sr) I and II were measured by ELISA CytoSets
(BioSource Europe, Nivelles, Belgium).
IL-6 sr was determined by in house ELISA. Results were
the mean of two results when samples were assayed in
duplicate.
The intra and inter assay coefficient of variation (CV)
were both <10% for all assays.
2.6. Statistical analysis
The incremental change in lactate, inflammatory medi-
ators, hormones and the decrement in SaO2 due to exercised
were expressed as a ratio of the total work done, to allow
comparisons to be made despite differences in the total work
performed. Increment= (post exercise valuepre-exercise
value) / total work done.
Analysis was performed with the SPSS software, version
10. Data is presented as arithmetic means and 95%
confidence intervals (95% CI). Analysis of variance and
the post hoc Tukey’s test were used to compare patients with
healthy subjects. ANOVA with Friedman’s test followed by
Wilcoxon test for two related samples was performed for
repeated measurements. Multiple stepwise regression was
used to investigate relationships between variables.3. Results
Only 11 patients were included in the final analysis
because of non-specific cross-reactivity in the IL-6Table 1
Anthropometrics, dyspnoea and physical activity scores, ventilatory parameters in p
(ANOVA followed by Tukey’s test)
Mean (95% CI) Patient
Age (years) 28.2 (
FEV1 (% predicted) 55.6 (
BMI (kg/m2) 23.0 (
FFMI (kg/m2) 15.6 (
Total work performed (kJ) 9.52 (
Exercise duration (s) 288.5 (
Work rate (power, W) 31.2 (
Borg score (10 point scale) 6.3 (
Habitual activity (Mets) 38.2 (
Lactate end of exercise (mmol/l) 3.6 (
VO2 end of exercise (ml/kg/min) 14.3 (
VO2 uptake (increment, l/kJ) 1.69 (
Respiratory rate increment, rate/min/kJ 2.33 (
VT increment, l/kJ 0.046 (
METs of work performed 3.098 (
Heart rate increment, rate/min/kJ 7.5 (assay, which led to unreliable results for one patient.
The BMI and FFMI were similar for patients and
healthy subjects (Table 1). Patients had lower levels of
habitual physical activity than the healthy subjects
( p <0.01, Table 1). The total work performed and the
duration of exercise was greater for healthy subjects (all
but 2 completed 20 min of exercise), but the work rate
was not different between patients and healthy subjects
(Table 1). None of the patients completed 20 min of
exercise. One patient completed 19 min, the mean
exercise time for patients was 4.80 min (Table 1). The
level of habitual physical activity (r2=0.78, p <0.001)
and FFMI (r2=0.34, p <0.01), but not FEV1 (r
2=0.21,
p =0.08) were determinants for the work done by the
patients.
3.1. Respiratory response to exercise
Oxygen uptake during the last minute of exercise and
the VO2 increment after exercise was greater for healthy
subjects than patients (Table 1). The rise in oxygen
uptake, VT, respiratory rate and heart rate per kilo-Joule
(kJ) of work done, were greater for patients (Table 1).
Oxygen saturation (SaO2) was less at the end of exercise
compared to baseline for patients than for healthy subjects
(94.6 (93.0, 96.3)% compared with 97.8 (97.0, 98.7)%,
p <0.05), and at the end of exercise 90.9 (87.3, 94.6) and
95.0 (94.1, 95.4) for patients and healthy subjects,
respectively. The exercise decrement in SaO2/kJ of work
done was greater for patients than healthy subjects; 2.16
(0.23, 4.08) and 0.20 (0.12, 0.28)%/kJ, p <0.05. For the
patients, FEV1 (r
2=0.70, p <0.001) was a determinant of
the reduction in SaO2 with exercise. The Borg score at
the end of exercise was greater for patients ( p <0.01),
Table 1.
The work performed, expressed in metabolic equivalents
(Mets), was greater for healthy subjects (Table 1).atients and healthy subjects; *p <0.01 between patients and healthy subjects
s (n =11) Healthy subjects (n =12)
23.3, 32.9) 29.9 (26.0, 33.7)
44.4, 66.8)
21.3, 24.6) 25.2 (22.5, 27.8)
14.6, 16.5) 16.5 (15.7, 17.2)
1.49, 17.56)* 40.3 (33.5, 47.2)
72.8, 504.24)* 1145.0 (1071.4, 1218.5)
27.6, 34.6) 35.1 (29.9, 40.3)
5.6, 7.2)* 4.6 (3.4, 5.9)
30.3, 46.2)* 64.7 (57.6, 71.8)
2.5, 4.6) 2.8 (1.9, 3.6)
10.8, 17.8)* 21.5 (19.7, 23.3)
1.11, 2.27)* 0.48 (0.39, 0.56)
1.12, 3.54)* 0.32 (0.24, 0.41)
0.033, 0.058)* 0.021 (0.018, 0.024)
3.01, 4.95)* 5.97 (5.48, 6.47)
4.3, 10.8)* 1.7 (1.4, 2.1)
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Fig. 1. Lactate concentrations at baseline, after exercise and 15, 30 and 120 min later. Continuous line—patients, interrupted line—healthy subjects. Data
presented as means and confidence intervals. Comparison between patients and healthy subjects was performed by ANOVA and post-hoc Tukey’s test.
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Plasma lactate levels were not different between patients
and healthy subjects at any assessment (Fig. 1). The lactate
increment at the end of exercise for patients and healthy
subjects was 1.58 (0.58, 2.58) and 1.10 (0.27, 1.93) mmol/l,
respectively. However, when related to the work done, the
increment was greater in patients than healthy subjects, 0.23
(0.08, 0.37) and 0.03 (0.006, 0.027) mmol/l/kJ, respectively,
p <0.01. The work done (r2=0.71, p <0.01) and habitual
physical activity (Mets) (r2=0.72, p <0.01) were determi-
nants of the lactate increment with exercise in the patients
only, but not the FEV1 (r
2=0.11) or SaO2 (r
2=0.02).
3.3. Inflammatory mediator and hormone responses to
exercise
The pre- and post-exercise concentrations of IL-6
( p <0.01), TNFa and soluble receptors (sr I and II)
( p <0.05) were greater for patients than healthy subjectsTable 2
Inflammatory mediators and hormone concentrations in patients and healthy subjec
healthy subjects by ANOVA followed by Tukey’s test)
Mean (95% CI) Patients
IL-6 (pg/ml) start** 3.73 (2.04, 5
End** 5.23 (3.35, 7
TNFa (pg/ml) start* 3.30 (1.90, 4
End* 3.34 (1.99, 4
IL-6 sr (pg/ml) start 42.8 (38.4, 4
End 47.6 (41.3, 5
TNFa srI (ng/ml) start* 1971.6 (1350.3
End* 2319.2 (1615.9
TNFa srII (ng/ml) start* 5111.0 (4012.4
End* 5028.5 (3907, 6
IGF1 start 128.6 (95.4, 1
End 114.8 (91.0, 1
Cortisol start 9.7 (6.1, 13
End 10.5 (7.5, 13
All peak concentrations occurred at the end of exercise.(Table 2). Peak values for inflammatory mediators occurred
at the completion of exercise in both patients and healthy
subjects (Table 2). For the patients IL-6 ( p <0.01), IL-6 sr
( p <0.05) and TNFa sr I ( p <0.05) were greater at the end
of exercise compared with pre-exercise, while in the healthy
subjects only IL-6 and IL-6 sr (both p <0.01, Fig. 2) were
greater at the end of exercise. The end of exercise increment
corrected for the work done was greater for patients for IL-
6, IL-6 sr, TNFa, TNFa srI and II (all p <0.01, Fig. 3).
In the 2 h post exercise period IL-6 levels remained greater
than at pre-exercise at 30 ( p <0.01) and 120 min ( p =0.016)
for patients, but only at 30 min ( p <0.05) for the healthy
subjects (Fig. 2). At 120 min IL-6 levels had not returned to
baseline in the patients. The absolute concentrations of all
other inflammatory mediators were not different from
baseline at 30 and 120 min. The absolute lactate increment
had an effect on the absolute IL-6 increment (r2=0.44,
p <0.01) for patients and healthy subjects as a group (n =23),
while the total work done had an effect on the IL-6 increment
only for patients (r2=0.74, p <0.01).ts at start and end of exercise; *p <0.05; **p <0.01 (comparing patients with
Healthy subjects
.43) 1.01 (0.60, 1.42)
.10) 1.24 (0.84, 1.64)
.78) 1.78 (1.32, 2.25)
.69) 1.79 (1.24, 2.34)
7.3) 36.7 (28.6, 44.8)
3.9) 41.7 (34.7, 48.6)
, 2593.0) 1543.6 (1025.0, 2062.3
, 3022.5) 1898.2 (852.8, 2943.5)
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149.4) 3158.7 (2072.1, 4245.3
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Fig. 2. IL-6 concentrations at baseline, after exercise and 15, 30 and 120 min later. Continuous line—patients, interrupted line—healthy subjects. Data
presented as means and confidence intervals. IL-6 was greater at the end of exercise than at baseline for both patients and healthy subjects ( p <0.01).
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in patients and healthy subjects and remained so at all
determinations (Table 2). There was no difference between
the pre-exercise levels of IGF1 or cortisol and the levels
2 h later. Blood glucose was unchanged at the end of exercise
compared to pre-exercise, for patients or healthy subjects.
3.4. Variability of the inflammatory mediators
For the eight patients who had repeated measurements in
a resting state, no difference was found at any assessment
point for any inflammatory mediator during the three days
(Friedman tests p non-significant). The greatest variability
was in IL-6 concentrations; mean (95% CI) ratio between
two consecutive measurements, where the greatest variation
was found, was 1.2 (1.1, 1.3), less than the response found
with exercise in patients, where the mean ratio between IL-6
concentration at the end and at the start of exercise was 1.47-0.5
0
0.5
1
1.5
2
2.5 p<0.01   p<0.05 
IL-6  IL-6 sr       TNFα
(pg/ml/kJ) (pg/ml/kJ)x10      (pg/ml/kJ)
Fig. 3. Post-exercise increment in inflammatory mediators. The increment was calc
of exerciseconcentration before exercise) /work performed and expressed in un
grey columns—patients; white columns—healthy subjects. ANOVAwith Friedman
comparisons between pre and post-exercise.(1.2, 1.91), while for healthy subjects it was 1.2 (1.12, 1.39).
For all other inflammatory mediators the variability between
assessments was less than for IL-6 (Table 3).4. Discussion
Low intensity exercise to subject defined exhaustion was
associated with a greater plasma lactate, pro-inflammatory/
pro-catabolic cytokine and anabolic and catabolic hormone
response in adults with CF compared with healthy subjects
completing greater amounts of exercise. The disproportion-
ate rise in lactate, IL-6, TNFa and their soluble receptors for
the work done confirms the reported response to exercise in
children with CF with mild to moderate severity lung
disease [8] and is similar to reported changes in adults with
COPD [22–24]. Female athletes with CF have disturbed
energy metabolism at a cellular level, despite normal lung     p<0.05 
TNFα srI TNFα srII
x10  (ng/ml/kJ)/100 (ng/ml/kJ)/100 
ulated for each inflammatory mediator as follows: (concentration at the end
its/kilo-Joule work. Results are presented as means and standard error bars,
’s test followed by Wilcoxon test for two related samples was performed for
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metabolism possibly linked to the lactate increment with
exercise [9].
Since the type of exercise likely to trigger an immediate
cytokine release in patients with lung disease is uncertain,
we chose to exercise subjects at a constant individual work
rate from which the total work performed was calculated
rather than use maximum exercise to exhaustion [8]. This
design allowed patients to exercise for a sufficient period to
obtain data, despite their ventilatory limitation, and achieve
a total work performance similar to that of light activities of
daily living, such as driving, lifting light objects and
vacuuming or ironing [20,21]. The conversion of work rate
into Mets and comparison with the habitual activity Mets
score indicated this criterion was achieved in this study.
However, comparison of the energy costs of the exercise
performed with the energy costs of daily activities needs to
be interpreted cautiously. The METs for daily activities were
calculated for non-CF individuals, while no data is available
for CF patients who have an increased resting energy
expenditure (REE). We used the METs simply to assess the
amount of exercise performed in metabolic equivalents,
which is unlikely to be dependent on the REE. The lack of
difference in absolute lactate levels between patients and
healthy subjects indicates that similar levels of metabolic
stress occurred in each individual in response to exercise.
However, the patients only completed approximately 25%
of the work done by the healthy subjects. It is likely that the
greater lactate response per unit of work in our patients was
due to impaired ventilation, reduced aerobic reserve,
metabolic changes in the exercising muscles involved and
altered oxygen uptake [8,9]. The oxygen uptake (ml/kg/min)
at the end of the exercise was significantly lower in the
patients compared to the healthy subject. However, when
reported as a ratio to the work performed the oxygen uptake
was greater for the patients, suggesting that for the same
work rate patients utilised more aerobic energy [8].
The greater IL-6, TNFa, TNFa sr I and II increment for
work performed in the patients suggests a lower threshold
for cytokine response in patients. We assessed the increment
rather than the absolute increase in the inflammatory
mediators in order to be able to compare the magnitude of
response to exercise, irrespective of the pre-exercise level,
to allow comparisons between patients and healthy individ-
uals who have different circulating levels of inflammatory
mediators. The persistence of the IL-6 response over the 2 h
post-exercise observation period was similar to the IL-6
response to running in healthy subjects, but for lesser total
work [7]. In healthy subjects the increase in circulating IL-6
may be immediate or delayed up to 2 h after completing the
exercise depending on the type undertaken [25]. Immediate
release of IL-6 may stimulate hepatic glycogenolysis to
maintain blood glucose and the uptake of glucose by
exercising muscles while later release of IL-6 may be related
to muscle injury and be important in muscle training. In
both patterns the effect of the increase in IL-6 is considered
A.A. Ionescu et al. / Journal of Cystic Fibrosis 5 (2006) 105–112 111to be advantageous by its action on the hypothalamic–
pituitary–adrenal axis with increased secretion of ACTH
and consequently glucocorticoids, which may provide either
improved substrate availability or an anti-inflammatory
response to increased pro-inflammatory, pro-catabolic cyto-
kines in skeletal muscle [26].
In contrast, increased levels of circulating IL-6 and TNFa
were associated with a reduced body cell and skeletal muscle
mass, reduced muscle strength and increased mortality in
healthy elderly subjects suggesting a possible link to age
related sarcopenia [15,27,28]. In patients with CF and COPD
increased circulating levels of IL-6, TNFa and their soluble
receptors were associated with a reduced FFM, skeletal
muscle and bone mass, and an increased number of
exacerbations [12,14,16]. In particular, these associations
with a low FFM held in patients when clinically stable [12].
Increased circulating TNFa in patients with HIV was related
to impaired protein synthesis in skeletal muscle after
treatment with growth hormone and TNFa sr were raised
in all clinical stages, but greatest in AIDS where they
indicate disease progression [29]. Further support for a
potentially disadvantageous effect of systemic inflammation
comes from the IL-6 transgenic mouse which constitutively
secretes IL-6 and develops a severe proteolytic myopathy,
reversed by an IL-6 receptor blocking antibody, which
indicates a role for IL-6 in muscle mass regulation [30]. In
vitro and in vivo studies with myocytes suggest that both IL-
6 and TNFa may have regulatory roles at a molecular level
in the maintenance of skeletal muscle status [31–35]. Hence,
our observation that increased IL-6, TNFa and their soluble
receptors following exercise occurs at a lower threshold in
patients may be of pathophysiological relevance.
Our findings demonstrate a resetting of the threshold for
the cytokine and lactate response to exercise in adults with
CF and moderate lung function impairment. In advancing
disease the lower threshold for the cytokine and the
persistence of such circulating mediators may allow such
cytokine surges to have catabolic effects and add to other
mechanisms underlying muscle loss, reduction in bone
mineral density, cachexia and physical disability in chronic
respiratory diseases. Further studies of these relationships
may indicate avenues for therapeutic interventions to
maintain muscle mass and function [36–38].Acknowledgements
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